No evidence of INI1hSNF5 (SMARCB1) and PARVG point mutations in oligodendroglial neoplasms

Cancer Genetics and Cytogenetics

Volumn 160, Issue 2, 2005, Pages 169-173

  Alonso, M Eva ^a   Bello, M Josefa ^a   De Campos, Jose M ^b   Isla, Alberto ^a   Vaquero, Jesús ^c   Gutierrez, Manuel ^a   Sarasa, Jose L ^d   Rey, Juan A ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DNA POLYMORPHISM; GENE; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIOMA; PARVG GENE; POINT MUTATION; PRIORITY JOURNAL; SMARCB1 GENE; TUMOR SUPPRESSOR GENE; DISEASE COURSE; EXON; GENETICS; INTRON; SINGLE STRAND CONFORMATION POLYMORPHISM;

ACTININ; DNA BINDING PROTEIN; NONHISTONE PROTEIN; PARVG PROTEIN, HUMAN; SMARCB1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ACTININ; BASE SEQUENCE; CHROMOSOMAL PROTEINS, NON-HISTONE; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; EXONS; GENES, TUMOR SUPPRESSOR; HUMANS; INTRONS; OLIGODENDROGLIOMA; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TRANSCRIPTION FACTORS;

EID: 21344474556     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2004.12.020     Document Type: Article

References (40)

1. J. Reifenberger, G. Reifenberger, L. Liu, C.D. James, W. Wechsler, and V.P. Collins Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p Am J Pathol 145 1994 1175 1190
2. M.J. Bello, P.E. Leone, J. Vaquero, J.M. de Campos, M.E. Kusak, J.L. Sarasa, A. Pestana, and J.A. Rey Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors Int J Cancer 64 1995 207 210
3. J.J. Zhu, T. Santarius, X. Wu, J. Tsong, A. Guha, J.K. Wu, T.J. Hudson, and P.M. Black Screening for loss of heterozygosity and microsatellite instability in oligodendrogliomas Genes Chromosomes Cancer 21 1998 207 216
4. J.S. Smith, B. Alderete, Y. Minn, T.J. Borell, A. Perry, G. Mohapatra, S.M. Hosek, D. Kimmel, J. O'Fallon, A. Yates, B.G. Feuerstein, P.C. Burger, B.W. Scheithauer, and R.B. Jenkins Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype Oncogene 18 1999 4144 4152
5. J. Felsberg, A. Erkwoh, M.C. Sabel, L. Kirsch, R. Fimmers, B. Blaschke, U. Schlegel, J. Schramm, O.D. Wiestler, and G. Reifenberger Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival Brain Pathol 14 2004 121 130
6. J.G. Cairncross, K. Ueki, M.C. Zlatescu, D.K. Lisle, D.M. Finkelstein, R.R. Hammond, J.S. Silver, P.C. Stark, D.R. Macdonald, Y. Ino, D.A. Ramsay, and D.N. Louis Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas J Natl Cancer Inst 90 1998 1473 1479
7. K. Husemann, M. Wolter, R. Buschges, J. Bostrom, M. Sabel, and G. Reifenberger Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gene from 1p32 in oligodendroglial tumors J Neuropathol Exp Neurol 58 1999 1041 1050 [Erratum in: J Neuropathol Exp Neurol 2000;59:88]
8. M.J. Bello, J.M. de Campos, J. Vaquero, P. Ruiz-Barnes, M.E. Kusak, J.L. Sarasa, and J.A. Rey hRAD54 gene and 1p high-resolution deletion-mapping analyses in oligodendrogliomas Cancer Genet Cytogenet 116 2000 142 147
9. M.E. Alonso, M.J. Bello, P. Gonzalez-Gomez, J. Lomas, D. Arjona, J.M. de Campos, M.E. Kusak, J.L. Sarasa, A. Isla, and J.A. Rey Mutation analysis of the p73 gene in nonastrocytic brain tumours Br J Cancer 85 2001 204 208
10. D. Chou, T. Miyashita, H.W. Mohrenweiser, K. Ueki, K. Kastury, T. Druck, A. von Deimling, K. Huebner, J.C. Reed, and D.N. Louis The BAX gene maps to the glioma candidate region at 19q13.3, but is not altered in human gliomas Cancer Genet Cytogenet 88 1996 136 140
11. S.M. Dong, J.C. Pang, W.S. Poon, J. Hu, K.F. To, A.R. Chang, and H.K. Ng Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors J Neuropathol Exp Neurol 60 2001 808 816
12. M. Wolter, J. Reifenberger, B. Blaschke, K. Ichimura, E.E. Schmidt, V.P. Collins, and G. Reifenberger Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes J Neuropathol Exp Neurol 60 2000 1170 1180
13. M.E. Alonso, M.J. Bello, P. Gonzalez-Gomez, D. Arjona, J. Lomas, J.M. de Campos, A. Isla, J.L. Sarasa, and J.A. Rey Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas Cancer Genet Cytogenet 144 2003 134 142
14. A.G. Knudson Antioncogenes and human cancer Proc Natl Acad Sci U S A 90 1993 10914 10921
15. P. Kleihues, D.N. Louis, B.W. Scheithauer, L.B. Rorke, G. Reifenberger, P.C. Burger, and W.K. Cavenee The WHO classification of tumors of the nervous system J Neuropathol Exp Neurol 61 2002 215 225
16. J.A. Rey, M.J. Bello, A.M. Jimenez-Lara, J. Vaquero, M.E. Kusak, J.M. de Campos, J.L. Sarasa, and A. Pestana Loss of heterozygosity for distal markers on 22q in human gliomas Int J Cancer 51 1992 703 706
17. A.K. Muhammad, T. Yoshimine, M. Maruno, K. Tokiyoshi, O. Takemoto, and T. Hayakawa Chromosome 22q allelic losses at microsatellite loci in human astrocytic tumors Neurol Med Chir (Tokyo) 37 1997 606 610
18. N.T. Oskam, E.H. Bijleveld, and T.J. Hulsebos A region of common deletion in 22q13.3 in human glioma associated with astrocytoma progression Int J Cancer 85 2000 336 339
19. C. Hartmann, A. Numann, W. Mueller, N. Holtkamp, M. Simon, and A. von Deimling Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma Int J Cancer 108 2004 839 844
20. T.J. Hulsebos, N.T. Oskam, E.H. Bijleveld, A. Westerveld, M.A. Hermsen, A.M. van den Ouweland, B.C. Hamel, and C.C. Tijssen Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2 Br J Cancer 81 1999 1150 1154
21. K. Lamszus, L. Lachenmayer, U. Heinemann, L. Kluwe, U. Finckh, W. Hoppner, D. Stavrou, R. Fillbrandt, and M. Westphal Molecular genetic alterations on chromosomes 11 and 22 in ependymomas Int J Cancer 91 2000 803 808
22. B. Huang, P. Starostik, J. Kuhl, J.C. Tonn, and W. Roggendorf Loss of heterozygosity on chromosome 22 in human ependymomas Acta Neuropathol (Berl) 103 2002 415 420
23. B.R. Seizinger, S. de la Monte, L. Atkins, J.F. Gusella, and R.L. Martuza Molecular genetic approach to human meningiomas: loss of genes on chromosome 22 Proc Natl Acad Sci U S A 84 1987 5419 5423
24. J.P. Dumanski, G.A. Rouleau, M. Nordenskjöld, and V.P. Collins Molecular genetic analysis of chromosome 22 in 81 cases of meningiomas Cancer Res 50 1990 5863 5867
25. D.T. Ransom, S.R. Ritland, D.W. Kimmel, C.A. Moertel, R.J. Dahl, B.W. Scheithauer, P.J. Kelly, and R.B. Jenkins Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas and oligodendrogliomas Genes Chromosomes Cancer 5 1992 348 356
26. R.B. Jenkins, D.W. Kimmel, C.A. Moertel, C.G. Schultz, B.W. Scheithauer, P.J. Kelly, and G.W. Dewald A cytogenetic study of 53 human gliomas Cancer Genet Cytogenet 39 1989 253 279
27. S.H. Bigner, M.R. Matthews, B.K.A. Rasheed, R.N. Wiltshire, H.S. Friedman, A.H. Friedman, T.T. Stenzel, D.M. Dawes, R.E. McLendon, and D.D. Bigner Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization Am J Pathol 155 1999 375 386
28. J.A. Biegel, J.Y. Zhou, L.B. Rorke, C. Stenstrom, L.M. Wainwright, and B. Fogelgren Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors Cancer Res 59 1999 74 79
29. P. Rieske, M. Zakrzewska, S. Piaskowski, D. Jaskolski, B. Sikorska, W. Papierz, K. Zakrzewski, and P.P. Liberski Molecular heterogeneity of meningioma with INI1 mutation Mol Pathol 56 2003 299 301
30. M. Weber, F. Stockhammer, U. Schmitz, and A. von Deimling Mutational analysis of INI1 in sporadic human brain tumors Acta Neuropathol (Berl) 101 2001 479 482
31. W. Mueller, J.H. Eum, U. Lass, W. Paulus, C. Sarkar, W. Bruck, and A. von Deimling No evidence of hSNF5/INI1 point mutations in choroid plexus papilloma Neuropathol Appl Neurobiol 30 2004 304 307
32. S. Castellví-Bel, A. Castells, C.N. Johnstone, V. Pinol, M. Pellise, J.I. Elizalde, N. Romo, A.K. Rustgi, and J.M. Pique Evaluation of PARVG located on 22q13 as a candidate tumor suppressor gene for colorectal and breast cancer Cancer Genet Cytogenet 144 2003 80 82
33. M.E. Alonso, M.J. Bello, D. Arjona, P. Gonzalez-Gomez, J. Lomas, J.M. de Campos, M.E. Kusak, A. Isla, and J.A. Rey Analysis of the NF2 gene in oligodendrogliomas and ependymomas Cancer Genet Cytogenet 134 2002 1 5
34. W. Wang, Y. Xue, S. Zhou, A. Kuo, B.R. Cairns, and G.R. Crabtree Diversity and specialization of mammalian SWI/SNF complexes Genes Dev 10 1996 2117 2130
35. G. Schnitzler, S. Sif, and R.E. Kingston Human SWI/SNF interconverts a nucleosome between its base state and a stable remodeled state Cell 94 1998 17 27
36. F. Grand, S. Kulkarni, A. Chase, J.M. Goldman, M. Gordon, and N.C. Cross Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia Cancer Res 59 1999 3870 3874
37. U. Schmitz, W. Mueller, M. Weber, N. Sevenet, O. Delattre, and A. von Deimling INI1 mutations in meningiomas at a potential hotspot in exon 9 Br J Cancer 84 2001 199 201
38. E. Korenbaum, T.M. Olski, and A.A. Noegel Genomic organization and expression profile of the parvin family of focal adhesion proteins in mice and humans Gene 279 2001 69 79
39. Y.W. Huang, R. Baluna, and E.S. Vitetta Adhesion molecules as targets for cancer therapy Histol Histopathol 12 1997 467 477
40. S.B. Baylin, and J.G. Herman DNA hypermethylation in tumorigenesis: epigenetics joins genetics Trends Genet 16 2000 168 174